In this review the authors delineate the current understanding of how TFEB dysregulation is involved in neurodegeneration. Because TFEB is a central node in defining autophagy activation status efforts at understanding the basis for TFEB dysfunction are yielding insights into how TFEB might be targeted for therapeutic application which may represent an exciting opportunity for the development of a treatment modality.
We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.